TNDM Stock Gains on the Commercial Launch of Control-IQ+ Technology [Yahoo! Finance]
Tandem Diabetes Care, Inc. (TNDM)
Last tandem diabetes care, inc. earnings: 4/30 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investor.tandemdiabetes.com
Company Research
Source: Yahoo! Finance
Control-IQ+ is compatible with both the t:slim X2 insulin pump and Tandem Mobi System. It is available for people with type 1 diabetes (ages 2 years and older) and adults with type 2 diabetes. Since the announcement, TNDM's shares edged up 1.1% at the after-market trading yesterday. Tandem Diabetes continues to strategically expand the adoption of its insulin pumps by type 1 and type 2 diabetic patients across all markets. The company is actively working with its product launch and commercial strategy to progress in the type 2 diabetes space. Accordingly, we expect the latest launch of Control-IQ+ technology to motivate market sentiment toward the TNDM stock to remain positive in the upcoming days. Tandem Diabetes currently has a market capitalization of $1.33 billion. It has estimated earnings per share (EPS) growth rate of 38.7% in 2025 compared with the industry's 15.6% growth. In the past 30 days, the company's loss per share has decreased from $2.55 to $1.17 for 2025. Con
Show less
Read more
Impact Snapshot
Event Time:
TNDM
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TNDM alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TNDM alerts
High impacting Tandem Diabetes Care, Inc. news events
Weekly update
A roundup of the hottest topics
TNDM
News
- TNDM Investor News: If You Have Suffered Losses in Tandem Diabetes Care, Inc. (NASDAQ: TNDM), You Are Encouraged to Contact The Rosen Law Firm About Your RightsGlobeNewswire
- Unpacking Q3 Earnings: Tandem Diabetes (NASDAQ:TNDM) In The Context Of Other Healthcare Technology Stocks [Yahoo! Finance]Yahoo! Finance
- Tandem Diabetes Care (NASDAQ:TNDM) was given a new $24.00 price target on by analysts at Truist Financial Corporation.MarketBeat
- Tandem t:slim Mobile App Now Available in CanadaBusiness Wire
- Rosen Law Firm Encourages Tandem Diabetes Care, Inc. Investors to Inquire About Securities Class Action Investigation - TNDMPR Newswire
TNDM
Earnings
- 11/6/25 - In-Line
TNDM
Sec Filings
- 12/17/25 - Form 4
- 12/17/25 - Form 4
- 12/8/25 - Form 4
- TNDM's page on the SEC website